“Curing HIV” October 22, 2009

Dr. Roger J. Pomerantz has published more than 300 peer-reviewed articles in scientific literature and presented more than 200 invited lectures, nationally and internationally, concentrating on the clinical research, molecular pathogenesis and latency of human immunodeficiency virus (HIV) and other pathogenic human viruses. Dr. Pomerantz has been the recipient of countless National Institutes of Health (N.I.H.) grants and was continuously funded by the N.I.H. over several decades.

Dr. Pomerantz has served as an invited full-time member and as the Chairman of the Antiviral Advisory Panel for the U.S. Food and Drug Administration (F.D.A.) and on numerous invited N.I.H. advisory commissions, panels and committees. His awards and honors have included election as a Fellow to the American Association of Physicians (F.A.A.P.), the American Society of Clinical Investigation (F.A.S.C.I.), the American College of Physicians (F.A.C.P.), and the Infectious Diseases Society of America (F.I.D.S.A.).

Dr. Pomerantz joined Johnson & Johnson, Inc. in 2005 as the president of Tibotec Pharmaceuticals, Inc, the virology and infectious diseases research and development company within Johnson & Johnson. In 2009, he was promoted to Global Head of Infectious Diseases for Johnson & Johnson Pharmaceuticals, with the responsiblity for all anti-infective agents world-wide (including virology, tuberculosis, anti-bacterial agents, and diagnostics).